801 related articles for article (PubMed ID: 22396480)
1. Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells.
Alemayehu D; Casey PG; McAuliffe O; Guinane CM; Martin JG; Shanahan F; Coffey A; Ross RP; Hill C
mBio; 2012; 3(2):e00029-12. PubMed ID: 22396480
[TBL] [Abstract][Full Text] [Related]
2. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients.
Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK
AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776
[TBL] [Abstract][Full Text] [Related]
3. Activity of Bacteriophages in Removing Biofilms of
Fong SA; Drilling A; Morales S; Cornet ME; Woodworth BA; Fokkens WJ; Psaltis AJ; Vreugde S; Wormald PJ
Front Cell Infect Microbiol; 2017; 7():418. PubMed ID: 29018773
[No Abstract] [Full Text] [Related]
4. Pseudomonas biofilms, cystic fibrosis, and phage: a silver lining?
Brüssow H
mBio; 2012; 3(2):. PubMed ID: 22493030
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of bacteriophages in the sputum of cystic fibrosis patients.
Saussereau E; Vachier I; Chiron R; Godbert B; Sermet I; Dufour N; Pirnay JP; De Vos D; Carrié F; Molinari N; Debarbieux L
Clin Microbiol Infect; 2014 Dec; 20(12):O983-90. PubMed ID: 24920209
[TBL] [Abstract][Full Text] [Related]
6. Design of a Broad-Range Bacteriophage Cocktail That Reduces Pseudomonas aeruginosa Biofilms and Treats Acute Infections in Two Animal Models.
Forti F; Roach DR; Cafora M; Pasini ME; Horner DS; Fiscarelli EV; Rossitto M; Cariani L; Briani F; Debarbieux L; Ghisotti D
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555626
[TBL] [Abstract][Full Text] [Related]
7. Bacteriophage Delivery by Nebulization and Efficacy Against Phenotypically Diverse Pseudomonas aeruginosa from Cystic Fibrosis Patients.
Sahota JS; Smith CM; Radhakrishnan P; Winstanley C; Goderdzishvili M; Chanishvili N; Kadioglu A; O'Callaghan C; Clokie MR
J Aerosol Med Pulm Drug Deliv; 2015 Oct; 28(5):353-60. PubMed ID: 25714328
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients.
Olszak T; Zarnowiec P; Kaca W; Danis-Wlodarczyk K; Augustyniak D; Drevinek P; de Soyza A; McClean S; Drulis-Kawa Z
Appl Microbiol Biotechnol; 2015 Jul; 99(14):6021-33. PubMed ID: 25758956
[TBL] [Abstract][Full Text] [Related]
9. Isolation of bacteriophages and their application to control Pseudomonas aeruginosa in planktonic and biofilm models.
Kwiatek M; Parasion S; Rutyna P; Mizak L; Gryko R; Niemcewicz M; Olender A; Łobocka M
Res Microbiol; 2017 Apr; 168(3):194-207. PubMed ID: 27818282
[TBL] [Abstract][Full Text] [Related]
10. Bacteriophages of Pseudomonas aeruginosa: long-term prospects for use in phage therapy.
Krylov VN
Adv Virus Res; 2014; 88():227-78. PubMed ID: 24373314
[TBL] [Abstract][Full Text] [Related]
11. [New Virulent Bacteriophages Active against Multiresistant Pseudomonas aeruginosa Strains].
Balarjishvili NSh; Kvachadze LI; Kutateladze MI; Meskhi TSh; Pataridze TK; Berishvili TA; Tevdoradze ESh
Prikl Biokhim Mikrobiol; 2015; 51(6):600-9. PubMed ID: 26859962
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of Pseudomonas aeruginosa veterinary isolates to Pbunavirus PB1-like phages.
Fujiki J; Furusawa T; Munby M; Kawaguchi C; Matsuda Y; Shiokura Y; Nakamura K; Nakamura T; Sasaki M; Usui M; Iwasaki T; Gondaira S; Higuchi H; Sawa H; Tamura Y; Iwano H
Microbiol Immunol; 2020 Nov; 64(11):778-782. PubMed ID: 32918505
[TBL] [Abstract][Full Text] [Related]
13. Phage Therapy Is Effective in a Mouse Model of Bacterial Equine Keratitis.
Furusawa T; Iwano H; Hiyashimizu Y; Matsubara K; Higuchi H; Nagahata H; Niwa H; Katayama Y; Kinoshita Y; Hagiwara K; Iwasaki T; Tanji Y; Yokota H; Tamura Y
Appl Environ Microbiol; 2016 Sep; 82(17):5332-9. PubMed ID: 27342558
[TBL] [Abstract][Full Text] [Related]
14. Characterization of five newly isolated bacteriophages active against Pseudomonas aeruginosa clinical strains.
Kwiatek M; Mizak L; Parasion S; Gryko R; Olender A; Niemcewicz M
Folia Microbiol (Praha); 2015 Jan; 60(1):7-14. PubMed ID: 24993480
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a novel Pseudomonas aeruginosa bacteriophage, KPP25, of the family Podoviridae.
Miyata R; Yamaguchi K; Uchiyama J; Shigehisa R; Takemura-Uchiyama I; Kato S; Ujihara T; Sakaguchi Y; Daibata M; Matsuzaki S
Virus Res; 2014 Aug; 189():43-6. PubMed ID: 24801109
[TBL] [Abstract][Full Text] [Related]
16. Bacteriophages in the experimental treatment of Pseudomonas aeruginosa infections in mice.
Saussereau E; Debarbieux L
Adv Virus Res; 2012; 83():123-41. PubMed ID: 22748810
[TBL] [Abstract][Full Text] [Related]
17. Classification of 17 newly isolated virulent bacteriophages of Pseudomonas aeruginosa.
Li L; Yang H; Lin S; Jia S
Can J Microbiol; 2010 Nov; 56(11):925-33. PubMed ID: 21076483
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Pseudomonas aeruginosa phage KPP21 belonging to family Podoviridae genus N4-like viruses isolated in Japan.
Shigehisa R; Uchiyama J; Kato S; Takemura-Uchiyama I; Yamaguchi K; Miyata R; Ujihara T; Sakaguchi Y; Okamoto N; Shimakura H; Daibata M; Sakaguchi M; Matsuzaki S
Microbiol Immunol; 2016 Jan; 60(1):64-7. PubMed ID: 26616567
[TBL] [Abstract][Full Text] [Related]
19. Utility of lytic bacteriophage in the treatment of multidrug-resistant Pseudomonas aeruginosa septicemia in mice.
Vinodkumar CS; Kalsurmath S; Neelagund YF
Indian J Pathol Microbiol; 2008; 51(3):360-6. PubMed ID: 18723958
[TBL] [Abstract][Full Text] [Related]
20. Phage therapy against Pseudomonas aeruginosa infections in a cystic fibrosis zebrafish model.
Cafora M; Deflorian G; Forti F; Ferrari L; Binelli G; Briani F; Ghisotti D; Pistocchi A
Sci Rep; 2019 Feb; 9(1):1527. PubMed ID: 30728389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
